Abstract:
Introduction. Remote pharmaceutical care, facilitated by modern
technology, has revolutionized access to pharmaceutical services. From
consulting in rural regions of the United States and Europe, to
significant savings in Australia, this practice is improving treatment
adherence and reducing costs despite technological and privacy
challenges.
Aim of the study. The aim of this study is to analyze global
experiences and perspectives on remote pharmaceutical care, assessing
its impact on the accessibility, quality and efficiency of pharmaceutical
services, and to identify the associated challenges and opportunities.
Material and methods. Remote pharmaceutical care, facilitated by
modern technology, has revolutionized access to pharmaceutical
services. From consulting in rural regions of the United States and
Europe, to significant savings in Australia, this practice is improving
treatment adherence and reducing costs despite technological and
privacy challenges.
Results. Review of published scientific resources on remote
pharmaceutical care highlighted numerous advantages. In particular,
increased access to pharmaceutical services in rural and remote areas, such as in rural US states and parts of Europe, was a strength. Patients
with reduced mobility and those in hard-to-reach regions benefited
from continuous consultation and monitoring. Improved adherence to
treatment was another notable outcome. Periodic counseling via digital
platforms has facilitated real-time tracking and adjustment of
treatments, with successful examples in the UK where diabetes patients
have demonstrated better management of blood glucose levels. The
reduction of costs associated with medical care has been confirmed by
several studies, especially in Australia, where remote care projects have
resulted in significant savings. Patients reported a high level of
satisfaction, appreciating the convenience and accessibility of services.
However, the challenges are not lacking; technological barriers and
limited digital skills are significant obstacles. In sub-Saharan Africa,
insufficient infrastructure limits the use of digital platforms. These
results highlight the remarkable potential of remote pharmaceutical
care, but also the need for continued efforts to overcome the identified
challenges.
Conclusions. Remote pharmaceutical care brings key benefits such
as increased accessibility, improved treatment adherence and reduced
costs. However, technological barriers and limited digital skills require
attention. Continued investment and education are vital to the success
of this practice.
